Ispore recently issued its award winners from its 2025 conference in May this May. The winners are listed below.
I am excited to declare that my podium presentation “Laying the amount of treatment value using alternative health benefits matrix: A case study of Osimrtinib, a subsidiary for elderly patients with EGFR mutated NSCLCGot an award for Best General Podium Research PresentationThis co-author was done with Rahul Shenoliker, Rachel Solomonson, Anuj Shah, Shansan Wang, Stephanie Wise; Sukhwinder Johal, Sara Sulivan and Sanjana Muthukrishnan.
https://www.ispor.org/conferences-ducation/conferences/Upcoming-conferences/ispor-2025/award- Winners
Best general poster research presentations
- Co132: Low disease activity/ rheumatoid arthritis experience inadequate reactions to biologic/ targeted synthetic disease-propelled antirometric drugs. Chandrashekhar Gopalakrishnan, Om 1, Inc., Boston, MA, USA
- EE93: In the United States (US), patients with chronic lymphocytic leukemia (CLL) first-line (1L) First-Line (1L) Fixed-Duration BCL2I vs. Treat-to-TU-Poori BTKI Regiment: Estimated Total Cost of Care (TCC) Care (TCC). Sophia s. Lee, Gencentake, Inc., South San Francisco, CA, USA
- Eph5: The progress of disability and the related costs in the event quickly study mysthania gravis patients in France. Cecile Blein, Argenx, Zwijnaarde, Belgium
- PT10: Heart failure external control hand study (Emulat-HCA Study) Rogi-reported result closing point simulation.
- Presenting Author: Oneka Ilooh, Practice, Sciences, and Health Result Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA
Best student poster research presentations
- Ee403: Estimation of family spillover effects of heart diseases: evidence from medical expenditure panel survey. Ruixi Yu, University of Southern California, Department of Pharmaceutical and Health Economics, School of Pharmacy, Los Angeles, CA, USA
- Eph152: Trends in heart and cancer mortality between residents of Texas with cancer between 2010 and 2019. Ted Sohan, Texas College of Pharmacy University, Graduate Students, Austin, TX, USA
- PT30: To develop trends in racial and ethnic inequalities in syphilis circulation among people pregnant in the United States from 2016 to 2023.
- Presenting Author: Yizhi Liang, University of Southern California, Pharmaceutical and Health Economics Department, School of Pharmacy, Los Angeles, CA, USA
Best new exploiter poster research presentations
- Pcr198: Evaluation of the impact of user-complexity on individual preferences for upper limb prosthetic selection: measurement equipment development for an untreated option use. Leslie Wilson, University of California, San Francisco, San Francisco, CA, USA
- PT13: Clinical-reported result-a rare opportunity for Label? Kristen a. Cribs, Alchemy, Manchester Center, VT, USA
- PT38: Sickle cell disease (SCD) assess the impact of digital ecosystem engagement on results in patients. Orlando Agrippa, Sanius. Elth, London, United Kingdom
Best general podium research presentations
- P2: In patients with healthcare resource usage (HCru) and metastatic melanoma, the cost nivolumab + relathlimab (NIVO + Rela) or Nivolumab + ipilumab (NIVO + ipi) receives. Justin Mose, Honor Health Research and Innovation Institute, Scotsdale, AZ, USA
- P17: Health inequality on health inequality and health inequality in Americans’ ideas. Julia F. Sleesco, University of Maryland School of Pharmacy, Associate Professor, Baltimore, MD, USA
- P38: The cost-effectiveness of the belimtab for the treatment of adults with lupus nephritis active in Canada. Justin Reimar, GSK, Mississaga, On, Canada
- P50: Setting the amount of treatment value using alternative health benefits matrix: a case study of Osimrtinib, a assistant for elderly patients with EGFR mutated NSCLC.Jason Shaffreen, FTI Consulting, Los Angeles, CA, USA
Best student podium research presentations
- P39: The cost-effectiveness of agents stabilizing transthiratin for the treatment of transthiratin amyloid cardiomyopathy (ATRT-CM). Kanya Shah, Illinois University, Pharmacy System Department, Result, and Policy, Chicago, IL, USA
- P40: The cost-effectiveness analysis of prolonged injections of second-generation antisicotic antisicotic antisicotic work in patients with schizophrenia in the United States. Cindy M. Chan, Pittsburgh University, School of Pharmacy, Pittsburgh, PA, USA
- P57: The frequency of iceer miscalculation and misinterpretation in published cost-efficiency analysis compared to more than two options.
- Presenting Author: Sara McCard, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA
Best new exploiter podium research presentations
- P6: Policy by Research: Including patient preferences for colorectal cancer treatment in health technology evaluation. Carina Oldon, University of Calgary, Coming School of Medicine, Calgary, Canada
- P13: Taking advantage of real -world data and NLP to identify metabolic dysfunction associated with risk metabolic dysfunction in general population. Or shaked, briya, oil aviv, Israel
- P16: Effect of hallucinations in synthetic health data on prognostic machine learning models. Lisa Pilgram, Eastern Ontario Research Institute’s Children Hospital, Ottawa, On, Canada
- P53: Alignment between CDA recommendations and PCPA dialogue results: discovery of factors affecting reimbursement success.McKenzie Mills, HTA-Hive, London, United Kingdom
